The pharmaceutical and clinical research sectors have officially entered peak conference season, marked by high-profile readouts, regulatory milestones, and shifting…
Read More

The pharmaceutical and clinical research sectors have officially entered peak conference season, marked by high-profile readouts, regulatory milestones, and shifting…
Read More
The landscape of generative artificial intelligence has grown increasingly fragmented over recent years, forcing modern professionals, developers, and enterprises to…
Read More
The UK’s Joint Committee on Vaccination and Immunisation (JCVI) has put forth a significant recommendation for the introduction of a…
Read More
Artificial intelligence tools have transcended their niche origins to become indispensable components of daily professional workflows across virtually every sector.…
Read More
UniQure has announced a significant turning point in its pursuit of regulatory approval for AMT-130, a pioneering gene therapy aimed…
Read More
The US Food and Drug Administration (FDA) has accepted priority review of the new drug application (NDA) for Roche’s investigational…
Read More
The US Food and Drug Administration (FDA) has accepted Bristol Myers Squibb’s (BMS) supplemental new drug application (sNDA) for Camzyos…
Read More
Sanofi has secured a significant milestone in its development of venglustat, an innovative oral glucosylceramide synthase inhibitor (GCSi), with the…
Read More
FastAPI has rapidly ascended to prominence as a cornerstone framework for building high-performance, asynchronous APIs in Python. Renowned for its…
Read More
The United States Food and Drug Administration (FDA) has granted priority review to a supplemental biologics license application (sBLA) from…
Read More